Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane H Buckner

Showing results (41-50 of 179) with videos related to

Pageof 18
Sort By:
Frontiers in Immunology|September 21, 2018
Increased Binding of Specificity Protein 1 to the <i>IL21R</i> Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid ArthritisElizabeth M Dam, Alison C Maier, Anne M Hocking, et al.
Frontiers in Immunology|June 4, 2019
Corrigendum: Increased Binding of Specificity Protein 1 to the <i>IL21R</i> Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid ArthritisElizabeth M Dam, Alison C Maier, Anne M Hocking, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2002
Defining antigen-specific responses with human MHC class II tetramersJane H Buckner, Ursula Holzer, Erik J Novak, et al.
Clinical Immunology (Orlando, Fla.)|October 16, 2012
Identification of novel HLA class II target epitopes for generation of donor-specific T regulatory cellsBrad Stone, Mary Rieck, Crystal A Rawlings, et al.
Elife|March 24, 2023
<i>PTPN22</i> R620W gene editing in T cells enhances low-avidity TCR responsesWarren Anderson, Fariba Barahmand-Pour-Whitman, Peter S Linsley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signalingAdrian F Arechiga, Tania Habib, Yantao He, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2017
The Autoimmune Risk Variant <i>PTPN22</i> C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive RepertoireGenita Metzler, Xuezhi Dai, Christopher D Thouvenel, et al.
Scientific Reports|October 12, 2017
S1P<sub>1</sub> deletion differentially affects TH17 and Regulatory T cellsAhmet Eken, Rebekka Duhen, Akhilesh K Singh, et al.
Arthritis Research & Therapy|September 19, 2021
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RAWilliam Rigby, Jane H Buckner, S Louis Bridges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
<i>CBLB</i> Deficiency in Human CD4<sup>+</sup> T Cells Results in Resistance to T Regulatory Suppression through Multiple MechanismsJing Song, Warren Anderson, Alex Hu, et al.
Pageof 18

Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Frontiers in Immunology|September 21, 2018
Increased Binding of Specificity Protein 1 to the <i>IL21R</i> Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid ArthritisElizabeth M Dam, Alison C Maier, Anne M Hocking, et al.
Frontiers in Immunology|June 4, 2019
Corrigendum: Increased Binding of Specificity Protein 1 to the <i>IL21R</i> Promoter in B Cells Results in Enhanced B Cell Responses in Rheumatoid ArthritisElizabeth M Dam, Alison C Maier, Anne M Hocking, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2002
Defining antigen-specific responses with human MHC class II tetramersJane H Buckner, Ursula Holzer, Erik J Novak, et al.
Clinical Immunology (Orlando, Fla.)|October 16, 2012
Identification of novel HLA class II target epitopes for generation of donor-specific T regulatory cellsBrad Stone, Mary Rieck, Crystal A Rawlings, et al.
Elife|March 24, 2023
<i>PTPN22</i> R620W gene editing in T cells enhances low-avidity TCR responsesWarren Anderson, Fariba Barahmand-Pour-Whitman, Peter S Linsley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signalingAdrian F Arechiga, Tania Habib, Yantao He, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 13, 2017
The Autoimmune Risk Variant <i>PTPN22</i> C1858T Alters B Cell Tolerance at Discrete Checkpoints and Differentially Shapes the Naive RepertoireGenita Metzler, Xuezhi Dai, Christopher D Thouvenel, et al.
Scientific Reports|October 12, 2017
S1P<sub>1</sub> deletion differentially affects TH17 and Regulatory T cellsAhmet Eken, Rebekka Duhen, Akhilesh K Singh, et al.
Arthritis Research & Therapy|September 19, 2021
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RAWilliam Rigby, Jane H Buckner, S Louis Bridges, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2022
<i>CBLB</i> Deficiency in Human CD4<sup>+</sup> T Cells Results in Resistance to T Regulatory Suppression through Multiple MechanismsJing Song, Warren Anderson, Alex Hu, et al.
Pageof 18